Cincera’s novel and differentiated approach to treating inflammatory and fibrotic conditions is derived from the academic research of our scientific co-founders and involves blocking a key enzymatic target in a lipid metabolism pathway. The inhibition of this enzyme not only blocks the formation of damaging pro-inflammatory and pro-fibrotic biolipids, but concomitantly leads to the accumulation of beneficial anti-inflammatory and anti-fibrotic biolipids in peripheral tissues.
This unique mechanism of action seeks to improve the quality rather than the quantity of lipids deposited in tissues in order to drive therapeutic benefit.
cinceratx.com
Some of these cookies are essential for the website to function correctly, while others may collect your personal information. In some cases, the personal information collected by our cookies may be shared with third party service providers.
For details about the categories of cookies that we use, and to set your cookie preferences, please select ‘More information’ before you continue. For an overview see our Privacy Statement, or review our Privacy Policy in full.